Healthcare Discoveries Inc. Central ECG Laboratory
Services Partner, the
Healthcare Discoveries Inc. (HCD) and Colorado Prevention Center (CPC) who together provide innovative central electrocardiography (ECG) laboratory services, announce that the CPC has achieved Mortara Certified Partner status after successfully implementing Mortara’s 12-lead Surveyor Telemetry System in Phase I studies. The CPC has been awarded these designations by Mortara as a result of the HCD and CPC collaboration designed to significantly advance cardiac safety in drug development through a seamless integration between the two organizations.
The Mortara Certified Partner Program recognizes cardiac central laboratories and academic institutions engaged in the analysis and annotation of digital ECG data. In collaboration with the U.S. Food and Drug Administration (FDA), Mortara has developed the E-Scribe ECG Warehouse, to receive, store and analyze cardiac safety data submitted in standardized data formats in support of New Drug Applications (NDAs). ECG data must pass a validation step in the E-Scribe ECG Warehouse system, to ensure adherence to the Health Level 7 (HL7) XML standard. FDA reviewers use the data warehouse system to process ECG data with advanced tools and viewing technologies.
As a result of the certified partner status and
implementation of the 12-lead Surveyor Telemetry System, sponsors can be
assured that when working with HCD Inc. and CPC,
ECG data will be acquired with optimized workflow and real-time monitoring of
signal quality. HCD Inc. and CPC investigators
apply uniform diagnostic standards when interpreting ECGs.
“We are excited that our partner, CPC, has been accepted into this ’elite club’
of ECG data providers. This enables us to optimize safety while providing our
Sponsors with high quality data and cost effective clinical solutions that they
have come to expect from our organizations” said Dr.
About Healthcare Discoveries Inc.
Established in 2000, Healthcare Discoveries Inc. (www.healthcare-discoveries.com)
is a wholly-owned division of Catalyst Pharma Group, Inc (www.catalystpharmagroup.com ).
HCD is composed of an industry dedicated Phase I/IIa facilitiy, with >115 bed (semi-private rooms) capacity,
located in
UK/EU Contact Kerry Dyson , +44
(781) 4930601
About
The
Contact Evan King: (303) 860-0712 x134
About Mortara
Mortara Instrument's headquarters
are located in